PRVB - Provention Bio names Christina Yi as COO Benedict Osorio Chief Quality Officer

Provention Bio (NASDAQ:PRVB) has appointed Christina Yi as Chief Operations Officer and Benedict Osorio as Chief Quality Officer, responsible for all aspects of quality.  Ms. Yi most recently served as Chief Operating Officer at Vaxxinity developing vaccines for neurological disorders and prevalent chronic disorders.  Mr. Osorio was Chief Operating Officer at Progenics Pharmaceuticals.  In connection with the hiring of Ms. Yi, the board of the company approved the grant to Ms. Yi of a stock option to purchase 300,000 shares of the company's common stock.  The stock option was granted with a 10-year term and an exercise price equal to $5.88. 50% of the options will vest based on the achievement of certain performance based milestones and the remaining 50% of the options will vest in equal annual installments of 12.5% beginning on the first anniversary of the grant date, so that 50% of the award will be fully vested on the four year anniversary of the grant date.

For further details see:

Provention Bio names Christina Yi as COO, Benedict Osorio Chief Quality Officer